Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bevacizumab as a modulator of wound healing following trabeculectomy surgery
2013-000395-15Phase 3Terminated
- Sponsor
- Moorfields Eye Hospital
- Start
- Jan 2016
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
Phase 3, randomised trial of bevacizumab in open-angle glaucoma (OAG) (2 arms), sponsored by Moorfields Eye Hospital. Primary endpoint: Primary outcome measures. Started Jan 2016; status: terminated.
02
Drugs
bevacizumab
03
Conditions
open-angle glaucoma (OAG)
Beyond the preview
Go deeper on 2013-000395-15.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2013-000395-15.